Advanced Cell Technology, Inc. focus' on the production of stem cells for the treatment of cell degenerative disease. The technology platform offers four distinct advantages over the competition:

- The technology utilizes nuclear transfer (cloning) technology to produce healthy cells or tissue of any type with an identical genetic match to the patient's own DNA. This eliminates the risk of the cells being rejected by the patient's immune system.

- The technology regenerates the cell lifespan, thereby making "young" cells available for aging patients.

- The technology allows for precise genetic modification at the cellular level to cure genetic disorders as part of the treatment process.

- The Reduced Complexity Library (RCL) technology offers an off-the-shelf product for acute indications where nuclear transfer is not appropriate.

The combination of these unprecedented advances - the ability to produce young cells of any kind, genetically modified in any way, genetically compatible with the patient - is the strength of Advanced Cell Technology's platform.